¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"leading circle mechanism"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® mechanism ÇÑ±Û ±âÀü, ¸ÞÄ¿´ÏÁò
¼³¸í   
  1. ¾î¶² Çö»óÀÌ ÀϾ±â±îÁöÀÇ °úÁ¤. 2. ±â°è·Ð. »ý¸íÇö»óÀÌ ¹«±â¹°°è¸¦ Áö¹èÇϰí Àִ °Í°ú °°Àº ¹°¸®Àû, È­ÇÐÀû ¹ýÄ¢¿¡ ±âÃʸ¦ µÐ´Ù´Â Çм³.
¿µ¹® mechanism ÇÑ±Û ¸ÞÄ¿´ÏÁò
¼³¸í   
  1. ¾î¶² Çö»óÀÌ ÀϾ±â±îÁöÀÇ °úÁ¤. 2. ±â°è·Ð. »ý¸íÇö»óÀÌ ¹«±â¹°°è¸¦ Áö¹èÇϰí Àִ °Í°ú °°Àº ¹°¸®Àû, È­ÇÐÀû ¹ýÄ¢¿¡ ±âÃʸ¦ µÐ´Ù´Â Çм³.
¿µ¹® defense mechanism ÇÑ±Û ¹æ¾î¸ÞÄ¿´ÏÁò
¼³¸í   
  1.»ýü°¡ ¿ÜºÎÀڱؿ¡ ´ëÇÏ¿© Àڽſ¡°Ô ÀÌ·Ó°Ô µÇ±â À§ÇÑ ÀÏ·ÃÀÇ ±âÀüÀ» ÅëĪÇϴ ¸».
  
  2.ÇÁ·ÎÀÌÆ®°¡ ¹àÈù Á¤½ÅºÐ¼®ÀÇ Áß½ÉÀû À̷Р°³³äÀÇ Çϳª, °¨Á¤Àû °¥µîÀ» ÇؼÒÇϰí, °³ÀÎÀ» ºÒ¾È¿¡¼­ Çعæ½Ã۱â À§ÇÑ ¹«ÀǽÄÀû Á¤½ÅÀÛ¿ë °úÁ¤ÀÌ´Ù. ¹æ¾î±âÀü¿¡´Â ¾ï¾Ð, µµÇÇ, ¹æ¾îÀû °ø°Ý, ¹Ýµ¿Çü¼º, Åõ»ç, ÀüÀ§, ½ÂÈ­, ÅõÀÔ, ÀÚÃ¥, ÅðÇà, °Ý¸®, ´ë¸®Çü¼º, »óȯ, Àüȯ, Çظ®, ´ë»ó, ºÎÁ¤ µîÀÌ ÀÖ´Ù.
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arterial circle
    µ¿¸Æ°í¸®
  • blur circle
    Âø¶õ¿ø
  • circle
    ¿ø, °í¸®
  • color circle
    »ö»ó¿ø
  • cerebral arterial circle
    ´ë³úµ¿¸Æ°í¸®
  • diffusion circle
    »ê¶õ¿ø
  • vascular circle
    ¸Æ°ü°í¸®
  • association mechanism
    ¿¬ÇÕ±âÀü
  • autoregulation mechanism
    ÀÚµ¿Á¶Àý±âÀü
  • adaptive mechanism
    ÀûÀÀ±âÀü
  • blood coagulation mechanism
    Ç÷¾×ÀÀ°í±âÀü
  • clotting mechanism
    ÀÀ°í±âÀü
  • compensatory mechanism
    º¸»ó±âÀü
  • consummatory reward mechanism
    ¼ºÃ뺸»ó±âÀü
  • control mechanism
    Á¶Àý±âÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circle
    ¿ø, °í¸®
  • mechanism
    ±âÀü
  • adaptive mechanism
    ÀûÀÀ±âÀü
  • blood coagulation mechanism
    Ç÷¾×ÀÀ°í±âÀü
  • protective mechanism
    ¹æ¾î±âÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • arterial circle
    µ¿¸Æ°í¸®
  • blur circle
    Âø¶õ¿ø
  • circle
    ¿ø, °í¸®
  • cerebral arterial circle
    ´ë³úµ¿¸Æ°í¸®
  • circle absorption system
    ¼øÈ¯Èí¼ö½Äȸ·Î
  • color circle
    »ö»ó¿ø
  • diffusion circle
    »ê¶õ¿ø
  • vascular circle
    ¸Æ°ü°í¸®
  • adaptive mechanism
    ÀûÀÀ±âÀü
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀÓ±âÀü
  • association mechanism
    ¿¬ÇÕ±âÀü
  • autoregulation mechanism
    ÀÚµ¿Á¶Àý±âÀü
  • blood coagulation mechanism
    Ç÷¾×ÀÀ°í±âÀü
  • catch mechanism
    Æ÷ȹ±âÀü
  • chemiosmotic mechanism
    È­ÇлïÅõ±âÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Willis circle
    Àª¸®½º ȯ(ü»)
  • arterial circle
    µ¿¸Æ°í¸®
  • greater arterial circle of iris
    ūȫ䵿¸Æ°í¸®
  • greater circle of iris
    ūȫäµÑ·¹
  • hour circle
    ½Ã°¢±Ç(ãÁÊÇÏê).
  • infant circle
    À¯¾Æ¿ë ¼øÈ¯(½Ä)ȸ·Î, ¼Ò¾Æ¼øÈ¯È¸·Î.
  • Defense mechanism
    ¹æ¾î±âÁØ
  • Duncans mechanism
    ´øÄ­±âÀü.
  • Hydrogen-ATP ase mechanism
    ¼ö¼Ò-¾Æµ¥³ë½Å»ïÀλêÈ¿¼Ò ±âÀÛ
  • adaptive mechanism
    ÀûÀÀ±âÀü(îêëëѦï®).
  • antibody feedback mechanism
    Ç×üµÇ¸ÔÀ̱â±âÀü.
  • arousal mechanism
    °¢¼º±âÀü
  • pilomotor mechanism
    ¸ð¹ß¿îµ¿±âÀü(¡­ê¡ÔÑ Ñ¦ï®).
  • pressoreceptive mechanism
    ¾Ð·Â¼ö¿ë±âÀü(äâæ³áôé»Ñ¦ï®).
  • proprioceptive mechanism
    °íÀ¯¼ö¿ëü±âÀü.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leading
    ³³Áßµ¶.
  • leading edge
    ¼±µµ¿¬.
  • leading substrate
    ¼±µµ±âÁú.
  • arterial circle
    µ¿¸Æ°í¸®
  • blur circle
    Âø¶õ¿ø(ó¹Õ¯ê­).
  • cerebral arterial circle
    ´ë³úµ¿¸Æ°í¸®
  • cerebral arterial circle ; circulus arteriosus cerebri
    ´ë³úµ¿¸Æ°í¸®.
  • circle absorption system
    ¼øÈ¯Èí¼ö½Ä.
  • circle of Willis
    Àª¸®½ºÈ¯(ü»)
  • circle of Zinn
    Âð¾¾Ç÷°ü°í¸®(·û)
  • circle of diffusion
    »ê¶õ¿ø, Âø¶õ¿ø
  • circle of least confusion
    ÃÖ¼ÒÂø¶õ¿ø
  • colo(u)r circle
    »ö»óȯ(ßäßÓü»).
  • cortical branches of cerebral arterial circle
    ´ë³úµ¿¸Æ°í¸®ÀÇ °ÑÁú°¡Áö, ³úµ¿¸ÆÈ¯ÀÇ ÇÇÁúÁö.
  • diffusion circle
    »ê¶õ¿ø
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Cerebral arterial circle
    ´ë³úµ¿¸Æ°í¸®
    [¿¾ ¿ë¾î] ´ë³úµ¿¸Æ·û
  • Arterial circle
    µ¿¸Æ°í¸®
    [¿¾ ¿ë¾î] µ¿¸Æ·û
  • Vascular circle
    ¸Æ°ü°í¸®
    [¿¾ ¿ë¾î] ¸Æ°ü·û
  • Lesser arterial circle of iris
    ÀÛÀºÈ«Ã¤µ¿¸Æ°í¸®
    [¿¾ ¿ë¾î] ¼Òȫ䵿¸Æ·û
  • Greater arterial circle of iris
    ūȫ䵿¸Æ°í¸®
    [¿¾ ¿ë¾î] ´ëȫ䵿¸Æ·û
  • Greater circle of iris
    ūȫäµÑ·¹
    [¿¾ ¿ë¾î] ´ëȫä·û
  • Lesser circle of iris
    ÀÛÀºÈ«Ã¤µÑ·¹
    [¿¾ ¿ë¾î] ¼Òȫä·û
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • leading
    ¼±µµ(à»Óô)
  • leading reactant
    ¼±µµ¹ÝÀÀÁ¦(à»ÓôÚãëëð¥)
  • leading strand
    ¼±µµ(à»Óô)°¡´Ú
  • leading substrate
    ¼±µµ±âÁú(à»ÓôѨòõ)
  • closed circle
    "´ÝÈù ¿ø(ê­),"
  • covalent circle
    "°øÀ¯°áÇÕ ¿ø(ÍìêóÌ¿ùêê­), (ÔÒ) circular covalent; covalently closed circle"
  • Hershey circle
    Çã½Ãȯ(ü»)
  • looped rolling circle model
    ·çÇÁÇü ȸÀü¿ø(üÞï®ê­)¸ðµ¨
  • nicked-circle
    Æ´ ¿ø(ê­)
  • open circle
    ¿­¸° ¿ø(ê­)
  • opposing rolling circle model
    ¿ªÈ¸Àü ¿øÇü(æ½üÞï®ê­û¡) ¸ðµ¨
  • relaxed circle
    ÀÌ¿Ï ¿ø(ì¬èÐê­)
  • rolling circle replication
    ±¸¸§ ¿øÇüº¹Á¦(ê­û¡ÜÜð²)
  • binary complex mechanism
    À̼ººÐ º¹ÇÕü ±âÀü(ì£à÷Ý ÜÜùêô÷Ѿï®)
  • cascade mechanism
    ij½ºÄÉÀÌµå ±âÀü(Ѧï®)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • circle
    ¿ø, ¼øÈ¯
  • vicious circle
    ¾Ç¼øÈ¯
  • check valve mechanism
    ýº§ºê±âÀü
  • defense mechanism
    ¹æ¾î±âÀü, ¹æ¾î±âÁ¦
  • mechanism
    ±âÀü, ±â±¸, ±â°è·Ð
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ccDNA closed circle deoxyribonucleic acid
WIBC Wiggins Interpresonal Behavior Circle
ALARM adjustable leg and ankle repositioning mechanism
AM Academic Medicine [journal]; actomyosin; acute myelofibrosis; adult male; adult monocyte; aerospace ...
BCM B-cell maturation; birth control medication; blood-clotting mechanism effects; body cell mass; body ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
DMT Defence Mechanism Test
DMI Defense Mechanism Inventory
PCAR presumed circle area ratio
RC rolling circle
RCR rolling circle replication
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • leading
    ³³ Áßµ¶
  • leading substrate
    ¼±µµ ±âÁú
  • Livingston's vicious circle
    Livingston ¾Ç¼øÈ¯
  • sensation circle
    °¨°¢±Ç
    ½ÇÁ¦·Î ÀÚ±ØµÈ Á¡ÀÇ °¨°¢ÀÌ ÆÛÁö´Â °Í.
  • action mechanism
    ÀÛ¿ë ±âÀü
    ¾î¶² ±â´ÉÀÌ ÀϾ°Ô µÇ´Â °úÁ¤°ú °æ°ú.
  • buccinator mechanism
    Çù±Ù ±âÀü
  • cap-snatching mechanism
    ĸ Å»Ãë ±âÀü
  • central biasing mechanism
    ÁßÃß ±³Â÷ ±âÀü
  • central nerve system mechanism
    ÁßÃß ½Å°æ°è ±âÀü
  • central nervous system mechanism
    ÁßÃß ½Å°æ°è ±âÀü
  • check valve mechanism
    ý º§ºê ±âÀü
  • chemiosmotic mechanism
    È­ÇÐ »ïÅõ ±âÀü
  • coping mechanism
    ´ëÇ× ±âÀü, ±Øº¹ ±âÀü, ´ëó ±âÁ¦, ÀûÀÀ ±âÀü
    Ưº°ÇÑ ÀÏÀ̳ª ¹®Á¦ ¶Ç´Â »óȲÀ» Á¶ÀýÇϱâ À§ÇÑ ÀǽÄÀû ¹× ÇൿÀû ³ë·Â.
  • external stress releasing mechanism
    ¿ÜÀμº ½ºÆ®·¹½º ÇØ¼Ò ±âÀü
  • idiopathic trigger point mechanism
    Ư¹ß¼º ¹ßÅëÁ¡ ±âÀü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
rolling circle mechanism <molecular biology> A mechanism of DNA replication in many viral DNAs, in bacterial f factors during mating and of certain DNAs in gene amplification in eukaryotes.
DNA synthesis starts with a cut in the + strand at the replication origin, the 5' end rolls out and replication starts at the 3' side of the cut around the intact circular DNA strand. Replication of the 5' end (tail) takes place by the formation of Okazaki fragments.
(18 Nov 1997)
leading edge The initial part of a wave form at maximum slope.
(05 Mar 2000)
leading lamella <cell biology> Anterior region of a crawling cell, such as a fibroblast, from which most cytoplasmic granules are excluded.
(18 Nov 1997)
leading strand The DNA strand that is synthesised continuously during replication
Compare: lagging strand.
(09 Oct 1997)
association mechanism The cerebral mechanism whereby the memory of past sensations may be compared or associated with present ones.
(05 Mar 2000)
biochemical mechanism This is the general term for any chemical reaction or series of reactions, usually mediated by enzymes, which produce a given physiological effect in a living organism.
(09 Oct 1997)
Cairns mechanism <molecular biology> A mechanism for the replication of a double stranded circular DNA molecule. Replication is initiated at a fixed point and proceeds either uni or bi directionally.
(18 Nov 1997)
gating mechanism Occurrence of the maximum refractory period among cardiac conducting cells approximately 2 mm proximal to the terminal Purkinje fibres in the ventricular muscle, beyond which the refractory period is shortened through a sequence of Purkinje cells, transitional cells, and muscular cells; gating mechanism may be a cause of ventricular aberration, bidirectional tachycardia, and concealed extrasystoles, a mechanism by which painful impulses may be blocked from entering the spinal cord.
Compare: gate-control theory.
(05 Mar 2000)
random mechanism A scheme for substrate binding and product release for a multisubstrate enzyme; for a two-substrate two-product enzyme with this mechanism, either substrate can bind first and, after the reaction has taken place, either product can be the first to dissociate from the enzyme. Brain hexokinase has a random mechanism. More complex random mechanisms exist for enzymes having more than two substrates.
(05 Mar 2000)
cassette mechanism <molecular biology> Term used for genes such as the a and _ genes that determine mating type in yeast, either one or the other is active.
In this gene conversion process, a double stranded nuclease makes a cut at a specific point in the MAT locus, the old gene is replaced with a copy of a silent gene from one or other flanking region and the new copy becomes active. As the process involves replacing one ready made construct with another in an active slot it is called a cassette mechanism.
(18 Nov 1997)
re-entrant mechanism The probable basis of most arrhythmias, requiring at least three criteria in the heart: 1. A loop circuit, 2. Unidirectional block, 3. Slowed conduction. Impulses enter the loop circuit and divide in both directions (blocked in one direction only), negotiate the loop circuit to the area of block where the slowed conduction has allowed the impulse to arrive at a time when the tissue proximal to the unidirectional block has recovered and will permit its passage in the opposite direction.
(05 Mar 2000)
mechanism The manner of combination of parts, processes, etc., which subserve a common function.
Origin: Gr. Mechan = machine
(18 Nov 1997)
mechanism-based inhibitor A competitive inhibitor that is converted to an irreversible inhibitor at the active site of the enzyme.
Synonym: mechanism-based inhibitor.
(05 Mar 2000)
ping-pong mechanism A special multisubstrate reaction in which, for a two-substrate, two-product (i.e., bi-bi) system, an enzyme reacts with one substrate to form a product and a modified enzyme, the latter then reacting with a second substrate to form a second, final product, and regenerating the original enzyme. An example of such a mechanism is found in the aminotransferases. More complex ping-pong mechanisms exist for enzymes having more than two substrates.
Synonym: double displacement mechanism.
(05 Mar 2000)
countercurrent mechanism A system in the renal medulla that facilitates concentration of the urine as it passes through the renal tubules.
See: countercurrent exchanger, countercurrent multiplier.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • defense mechanism
    Àڱ⠹æÀ§±âÁ¦
  • escape mechanism
    (½É)µµÇÇ ±âÁ¦
  • mechanism
    ±â°è(ÀåÄ¡);±â±¸;Á¶Á÷;±â±³;¿ìÁÖ ±â°è·Ð
  • leading
    ÁÖµÈ
  • leading
    À̲ô´Â;ÁöÈÖÇÏ´Â;ÁÖ¿ªÀÇ;ÁÖ¿äÇÑ;ÈǸ¢ÇÑ;¼¼·ÂÀÖ´Â
  • leading
    Áöµµ;ÁöÇ¥;Åë¼Ö(·Â)
  • leading article
    »ç¼³
  • leading case
    ¼±·Ê°¡ µÇ´Â ÆÇ°á·Ê
  • leading lady
    ÁÖ¿¬¿©¿ì
  • leading part
    ÁÖ¿ª
  • leading question
    À¯µµ½É¹®
  • leading rein
    (¸» µûÀ§ÀÇ) ²ô´Â ÁÙ
  • leading strings
    (¾Æ±âÀÇ °Å¸§¸¶ ¿¬½À¿ë) ²ö;Áöµµ;in ~ È¥ÀÚ °ÈÁö ¸øÇϰí
  • circle
    Áý´Ü
  • Arctik Circle
    ºÏ±Ø±Ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á